NEW YORK (GenomeWeb News) – CombiMatrix said today that it has entered into an agreement with Stratose to provide coverage for its menu of diagnostic laboratory services, including its CombiSNP chromosomal microarray test.

Atlanta-based Stratose maintains a large preferred provider organization network in the US, including more than 850,000 direct and affiliate medical, dental, and workers' compensation provider contracts. Members of these plans will now have access to CombiMatrix's suite of tests for use in prenatal, miscarriage, and pediatric healthcare.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.